Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.92.23 CHF
Change Today -1.60 / -1.71%
Volume 300.0K
NOVNEE On Other Exchanges
New York
SIX Swiss Ex
SIX Swiss Ex
As of 11:05 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - novartis ag-2nd line (NOVNEE)

NameBoard RelationshipsTitleAge
Joseph Jimenez Jr., MBA19 RelationshipsChief Executive Officer55
Harry Kirsch 13 RelationshipsChief Financial Officer49
Mark C. Fishman M.D.No RelationshipsPresident of Institutes for Biomedical Research (NIBR)64
Bruno Strigini No RelationshipsPresident of Novartis Oncology--
André Wyss No RelationshipsGlobal Head of Novartis Business Services and Country President of Switzerland47

Board Members - novartis ag-2nd line (NOVNEE)

NameBoard RelationshipsPrimary CompanyAge
Joerg Reinhardt Ph.D.12 RelationshipsNovartis Consumer Health, Inc.59
Enrico Vanni Ph.D.35 RelationshipsNovartis AG64
Alex Krauer Ph.D.18 RelationshipsNovartis AG--
Daniel L. Vasella M.D.118 RelationshipsXBiotech, Inc.62
Pierre Landolt Ph.D.27 RelationshipsSandoz Family Foundation, Endowment Arm68

Executive Committees* - novartis ag-2nd line (NOVNEE)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeSrikant T. Madhav Datar Ph.D. 53 Relationships4 Executives
Compensation CommitteeEnrico Vanni Ph.D. 35 Relationships4 Executives
Nominating CommitteePierre Landolt Ph.D. 27 Relationships3 Executives
Corporate Governance CommitteePierre Landolt Ph.D. 27 Relationships3 Executives
View NOVNEE Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVNEE:SW SFr.92.23 CHF -1.60

NOVNEE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $102.47 USD +0.56
Johnson & Johnson $91.27 USD -1.37
Merck & Co Inc $51.86 USD -0.79
Nestle SA SFr.70.60 CHF -0.50
Sanofi €87.01 EUR -2.50
View Industry Companies

Industry Analysis


Industry Average

Valuation NOVNEE Industry Range
Price/Earnings 24.8x
Price/Sales 4.6x
Price/Book 3.0x
Price/Cash Flow 13.4x
TEV/Sales 4.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-2ND LINE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at